FDA Issues Guidelines For Back-And-Forth In Device Reviews
The U.S. Food and Drug Administration on Tuesday released new guidelines on how the agency should communicate with medical device makers during the review process, part of last year's user fee...To view the full article, register now.
Already a subscriber? Click here to view full article